Evidence map›Paper›PMID 27187907›Full record

ReviewMaternal & child nutrition2016

Childhood stunting: a global perspective.

Mercedes de Onis, Francesco Branca

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in Maternal & child nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 528 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
528citing papers in PubMed, 5 pooled it
58.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05608928 phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia

TypeinterventionalSponsorTropical Gastroenterology & Nutrition Group (TROPGAN)Ran2022 to 2023Enrolled76ConditionsEnvironmental EnteropathyArmsVSL#3, Capscan device, Placebo
NCT06405360 naterminatednot on this mapstarted 2024, after this paper: background citation

DEUX OEUFs:Cracking the Potential of Eggs to Improve Child Growth and Development

TypeinterventionalSponsorUniversity of FloridaRan2024 to 2026Enrolled464ConditionsInfant Malnutrition, Fetal Growth RetardationArmsEgg consumption
3 · Its place in the literature

Who cites it

528 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,524 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. [Advances in growth impairment associated with pediatric respiratory diseases].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  17. Review
  18. Article
  19. Article
  20. Review

468 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mercedes de OnisDepartment of Nutrition for Health and Development, World Health Organization, Geneva, Switzerland.
Francesco BrancaDepartment of Nutrition for Health and Development, World Health Organization, Geneva, Switzerland.
World Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Childhood stunting is the best overall indicator of children's well-being and an accurate reflection of social inequalities. Stunting is the most prevalent form of child malnutrition with an estimated 161 million children worldwide in 2013 falling below -2 SD from the length-for-age/height-for-age World Health Organization Child Growth Standards median. Many more millions suffer from some degree of growth faltering as the entire length-for-age/height-for-age z-score distribution is shifted to the left indicating that all children, and not only those falling below a specific cutoff, are affected. Despite global consensus on how to define and measure it, stunting often goes unrecognized in communities where short stature is the norm as linear growth is not routinely assessed in primary health care settings and it is difficult to visually recognize it. Growth faltering often begins in utero and continues for at least the first 2 years of post-natal life. Linear growth failure serves as a marker of multiple pathological disorders associated with increased morbidity and mortality, loss of physical growth potential, reduced neurodevelopmental and cognitive function and an elevated risk of chronic disease in adulthood. The severe irreversible physical and neurocognitive damage that accompanies stunted growth poses a major threat to human development. Increased awareness of stunting's magnitude and devastating consequences has resulted in its being identified as a major global health priority and the focus of international attention at the highest levels with global targets set for 2025 and beyond. The challenge is to prevent linear growth failure while keeping child overweight and obesity at bay.

Indexed as

Growth DisordersBody HeightChild, PreschoolCognition DisordersHumansInfantInfant, NewbornNeurodevelopmental DisordersReference ValuesRisk FactorsWorld Health Organizationchild developmenthealthy growthinfant and child growthmalnutritionstunting

Identifiers

PMID27187907
PMCPMC5084763
OpenAlexW2401598834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.